Literature DB >> 21098157

Survival and morbidity outcomes for very low birth weight infants with Down syndrome.

Nansi S Boghossian1, Nellie I Hansen, Edward F Bell, Barbara J Stoll, Jeffrey C Murray, Abbot R Laptook, Seetha Shankaran, Michele C Walsh, Abhik Das, Rosemary D Higgins.   

Abstract

OBJECTIVE: Our objective was to compare survival and neonatal morbidity rates between very low birth weight (VLBW) infants with Down syndrome (DS) and VLBW infants with non-DS chromosomal anomalies, nonchromosomal birth defects (BDs), and no chromosomal anomaly or major BD.
METHODS: Data were collected prospectively for infants weighing 401 to 1500 g who were born and/or cared for at one of the study centers participating in the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network in 1994-2008. Risk of death and morbidities, including patent ductus arteriosus (PDA), necrotizing enterocolitis (NEC), late-onset sepsis (LOS), retinopathy of prematurity, and bronchopulmonary dysplasia (BPD), were compared between VLBW infants with DS and infants in the other groups.
RESULTS: Infants with DS were at increased risk of death (adjusted relative risk: 2.47 [95% confidence interval: 2.00-3.07]), PDA, NEC, LOS, and BPD, relative to infants with no BDs. Decreased risk of death (relative risk: 0.40 [95% confidence interval: 0.31-0.52]) and increased risks of NEC and LOS were observed when infants with DS were compared with infants with other non-DS chromosomal anomalies. Relative to infants with nonchromosomal BDs, infants with DS were at increased risk of PDA and NEC.
CONCLUSION: The increased risk of morbidities among VLBW infants with DS provides useful information for counseling parents and for anticipating the need for enhanced surveillance for prevention of these morbidities.

Entities:  

Mesh:

Year:  2010        PMID: 21098157      PMCID: PMC3059605          DOI: 10.1542/peds.2010-1824

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  29 in total

1.  Determinants of survival in children with congenital abnormalities: a long-term population-based cohort study.

Authors:  Mohammad M Agha; Jack I Williams; Loraine Marrett; Teresa To; Linda Dodds
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-01

2.  Cardiovascular malformations among preterm infants.

Authors:  Kirsty Tanner; Nilofer Sabrine; Christopher Wren
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

Review 3.  Epidemiology of Down syndrome.

Authors:  Stephanie L Sherman; Emily G Allen; Lora H Bean; Sallie B Freeman
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2007

4.  Overexpression of copper-zinc superoxide dismutase in trisomy 21.

Authors:  R De La Torre; A Casado; E López-Fernández; D Carrascosa; V Ramírez; J Sáez
Journal:  Experientia       Date:  1996-09-15

5.  National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001.

Authors:  Mark A Canfield; Margaret A Honein; Nataliya Yuskiv; Jian Xing; Cara T Mai; Julianne S Collins; Owen Devine; Joann Petrini; Tunu A Ramadhani; Charlotte A Hobbs; Russell S Kirby
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-11

6.  A lack of neuroblastoma in Down syndrome: a study from 11 European countries.

Authors:  D Satgé; A J Sasco; N L Carlsen; C A Stiller; H Rubie; B Hero; B de Bernardi; J de Kraker; C Coze; P Kogner; F Langmark; F G Hakvoort-Cammel; D Beck; N von der Weid; S Parkes; O Hartmann; R J Lippens; W A Kamps; D Sommelet
Journal:  Cancer Res       Date:  1998-02-01       Impact factor: 12.701

7.  Proteins with an endostatin-like domain in a mouse model of oxygen-induced retinopathy.

Authors:  C A May; A V Ohlmann; H Hammes; U H M Spandau
Journal:  Exp Eye Res       Date:  2005-08-24       Impact factor: 3.467

8.  Risk of vascular anomalies with Down syndrome.

Authors:  Arin K Greene; Sendia Kim; Gary F Rogers; Steven J Fishman; Bjorn R Olsen; John B Mulliken
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

9.  An increase in superoxide dismutase ameliorates oxygen-induced retinopathy in transgenic mice.

Authors:  A Spierer; R Rabinowitz; S Pri-Chen; M Rosner
Journal:  Eye (Lond)       Date:  2005-01       Impact factor: 3.775

10.  DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease.

Authors:  Soo-Ryoon Ryoo; Hey Kyeong Jeong; Chinzorig Radnaabazar; Jin-Ju Yoo; Hyun-Jeong Cho; Hye-Won Lee; In-Sook Kim; Young-Hee Cheon; Young Soo Ahn; Sul-Hee Chung; Woo-Joo Song
Journal:  J Biol Chem       Date:  2007-09-28       Impact factor: 5.157

View more
  9 in total

1.  Palivizumab use in infants with Down syndrome-report from the German Synagis™ Registry 2009-2016.

Authors:  Arne Simon; Susanne Gehrmann; Gudrun Wagenpfeil; Stefan Wagenpfeil
Journal:  Eur J Pediatr       Date:  2018-04-12       Impact factor: 3.183

2.  NICU management and outcomes of infants with trisomy 21 without major anomalies.

Authors:  Sarah McAndrew; Krishna Acharya; T Hang Nghiem-Rao; Steven Leuthner; Reese Clark; Joanne Lagatta
Journal:  J Perinatol       Date:  2018-05-25       Impact factor: 2.521

3.  Differences in mortality characteristics in neonates with Down's syndrome.

Authors:  C L Cua; U Haque; S Santoro; L Nicholson; C H Backes
Journal:  J Perinatol       Date:  2017-01-12       Impact factor: 2.521

Review 4.  One size will never fit all: the future of research in pediatric transfusion medicine.

Authors:  Cassandra D Josephson; Traci Heath Mondoro; Daniel R Ambruso; Rosa Sanchez; Steven R Sloan; Naomi L C Luban; John A Widness
Journal:  Pediatr Res       Date:  2014-08-13       Impact factor: 3.756

5.  An exclusively human milk diet reduces necrotizing enterocolitis.

Authors:  Kenneth Herrmann; Katherine Carroll
Journal:  Breastfeed Med       Date:  2014-03-03       Impact factor: 1.817

6.  Trends in survival among children with Down syndrome in 10 regions of the United States.

Authors:  James E Kucik; Mikyong Shin; Csaba Siffel; Lisa Marengo; Adolfo Correa
Journal:  Pediatrics       Date:  2012-12-17       Impact factor: 7.124

7.  Ten-year review of major birth defects in VLBW infants.

Authors:  Ira Adams-Chapman; Nellie I Hansen; Seetha Shankaran; Edward F Bell; Nansi S Boghossian; Jeffrey C Murray; Abbot R Laptook; Michele C Walsh; Waldemar A Carlo; Pablo J Sánchez; Krisa P Van Meurs; Abhik Das; Ellen C Hale; Nancy S Newman; M Bethany Ball; Rosemary D Higgins; Barbara J Stoll
Journal:  Pediatrics       Date:  2013-06-03       Impact factor: 7.124

Review 8.  Necrotizing Enterocolitis in Children with Congenital Heart Disease: A Literature Review.

Authors:  Sean T Kelleher; Colin J McMahon; Adam James
Journal:  Pediatr Cardiol       Date:  2021-09-12       Impact factor: 1.655

Review 9.  Clinical Characteristics and Potential Pathogenesis of Cardiac Necrotizing Enterocolitis in Neonates with Congenital Heart Disease: A Narrative Review.

Authors:  Kathryn Y Burge; Aarthi Gunasekaran; Marjorie M Makoni; Arshid M Mir; Harold M Burkhart; Hala Chaaban
Journal:  J Clin Med       Date:  2022-07-09       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.